Robustness of nanofiltration for increasing the viral safety margin of biological products.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biologicals (Print)

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.biologicals.2013.10.003PMID 24485384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of varying virus‐spiking conditions on a virus‐removal filter Planova™ 20N in a virus validation study of antibody solutions

  2011cited by this paper
• Viral safety characteristics of Flebogamma DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin.

  2010cited by this paper
• Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies

  2009cited by this paper
• Effectiveness of nanofiltration in removing small non‐enveloped viruses from three different plasma‐derived products

  2009cited by this paper
• Viral clearance using disposable systems in monoclonal antibody commercial downstream processing

  2008cited by this paper
• Safety procedures of coagulation factors

  2007cited by this paper
• Viral safety of C1-inhibitor NF.

  2007cited by this paper
• Implementation of a 20‐nm pore‐size filter in the plasma‐derived Factor VIII manufacturing process

  2006cited by this paper
• Viral safety of Nanogam®, a new 15 nm‐filtered liquid immunoglobulin product

  2006cited by this paper
• Nanofiltration of single plasma donations: feasibility study

  2003cited by this paper
• Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.

  2002cited by this paper
• Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.

  1998cited by this paper
• Value of Virus Filtration as a Method for Improving the Safety of Plasma Products

  1996cited by this paper
• Removal of virus through novel membrane filtration method.

  1996cited by this paper
• Virus removal studies using nanofiltration membranes.

  1996cited by this paper
• Nanofiltration, a New Specific Virus Elimination Method Applied to High‐Purity Factor IX and Factor XI Concentrates

  1994cited by this paper
• Note for guidance. Guidelines for medicinal products derived from human blood and plasma. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.

  1992cited by this paper
• Strategies to produce virus-safe blood derivatives.

  1989cited by this paper
• Measures to inactivate viral contaminants of pooled plasma products.

  1985cited by this paper
• Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche

  1931cited by this paper

• Impact of proteins and protein fouling on virus retention during virus removal filtration

  2023cites this paper
• Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology

  2023cites this paper
• Determination of optimum nanofiltration conditions for the manufacturing process of human normal immunoglobulin G for intravenous administration

  2023cites this paper
• Nanofiltration for blood products

  2022cites this paper
• Global pore blockage - Cake filtration model including pressure effects on protein fouling in virus filtration

  2022cites this paper
• Mechanistic insights into flow-dependent virus retention in different nanofilter membranes

  2021cites this paper
• The Role of Nanofiltration in the Pathogen Safety of Biologicals: An Update

  2020cites this paper
• Two-Step Size-Exclusion Nanofiltration of Prothrombin Complex Concentrate Using Nanocellulose-Based Filter Paper

  2020cites this paper
• Determination of parvovirus retention profiles in virus filter membranes using laser scanning microscopy

  2020cites this paper
• Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells

  2020cites this paper
• COVID-19 and immunomodulation treatment for women with reproductive failures

  2020cites this paper
• Human platelet lysates for human cell propagation

  2020cites this paper
• Prospective, Randomized, Phase II, non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis during Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery.

  2019cites this paper
• Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step.

  2019cites this paper
• Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles

  2019cites this paper
• A Review on the Applications of Nanofiltration in Virus Removal and Pharmaceutical Industries

  2018cites this paper
• A Prospective, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Fibrin Sealant Grifols as an Adjunct to Hemostasis as Compared to Cellulose Sheets in Hepatic Surgery Resections

  2018cites this paper
• A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Soft Tissue Open Surgery

  2018cites this paper
• Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

  2017cites this paper
• Virome of US bovine calf serum.

  2017influential citation
• Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal

  2017cites this paper
• A Prospective, Randomized, Multicenter Clinical Trial on the Safety and Efficacy of a Ready-to-Use Fibrin Sealant as an Adjunct to Hemostasis during Vascular Surgery.

  2017cites this paper
• Pathogen inactivation of blood derived biological medicines: review article

  2017cites this paper
• Virus Reduction of Human Plasma-Derived Biological Medicines

  2017cites this paper
• Cellulose-based virus-retentive filters: a review

  2017influential citation
• Zika virus infection and biological treatment for reproductive medicine

  2017cites this paper
• Pathogen Inactivation Plays an Irreplaceable Role in Safeguarding theSafety of Blood Transfusion

  2016cites this paper
• Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia

  2016cites this paper
• Fundamental Strategies for Viral Clearance Part 2 : Technical Approaches

  2015cites this paper
• Measurement of pore size distribution and prediction of membrane filter virus retention using liquid–liquid porometry

  2015cites this paper
• Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections

  2014cites this paper